Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) has provided an announcement.
Rapid Dose Therapeutics Corp. will issue 362,708 common shares to holders of its secured convertible notes to satisfy approximately $47,154 in quarterly interest accrued as of December 31, 2025, with issuance expected by January 15, 2026. The interest payment in shares stems from an amended and restated note financing originally completed in 2023, under which the company extended the maturity of $3.08 million in promissory notes and associated warrants to November 30, 2026; the notes carry an 18% annual interest rate payable in stock at the Canadian Securities Exchange quarter-end closing price, a structure that preserves cash but dilutes existing shareholders while providing continued support from noteholders.
The most recent analyst rating on (TSE:DOSE) stock is a Hold with a C$0.13 price target. To see the full list of analyst forecasts on Rapid Dose Therapeutics Corp stock, see the TSE:DOSE Stock Forecast page.
Spark’s Take on TSE:DOSE Stock
According to Spark, TipRanks’ AI Analyst, TSE:DOSE is a Neutral.
The score is held down primarily by weak financial quality (ongoing losses, cash burn, and negative equity) and bearish technicals (below major moving averages with negative MACD). A positive partnership extension and commercialization progress provide some upside support, but valuation signals are limited due to losses and no dividend data.
To see Spark’s full report on TSE:DOSE stock, click here.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company focused on innovative drug delivery solutions. Its flagship product, QuickStrip™, is a thin, orally dissolvable film that can be infused with a wide range of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, designed for rapid absorption into the bloodstream.
Average Trading Volume: 30,614
Technical Sentiment Signal: Sell
Current Market Cap: C$19.12M
For a thorough assessment of DOSE stock, go to TipRanks’ Stock Analysis page.